Listening for Leisure After Stroke (MELLO)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02259062 |
Recruitment Status : Unknown
Verified July 2016 by NHS Greater Glasgow and Clyde.
Recruitment status was: Active, not recruiting
First Posted : October 8, 2014
Last Update Posted : July 6, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Stroke is the biggest cause of disability in older adults. Early poststroke rehabilitation focuses primarily on physical disability and activities of daily living. By contrast, relatively little research attention has been paid to the potential for cognitive rehabilitation and mood enhancing interventions in the early stages after stroke. Low mood and cognitive difficulties with attention and memory are common post stroke leading to poorer recovery, emotional wellbeing and quality of life yet accessible and effective therapies are lacking.
Engagement in leisure activities may enhance recovery after stroke but participation in leisure activities is reduced following stroke. Music listening is a low cost and accessible leisure activity that has been suggested to improve mood and cognition poststroke. The investigators speculate that music listening may enhance control of attention in a similar way to mindfulness interventions, that have been demonstrated to be beneficial in the treatment of mood disorders. The investigators propose that adding a brief mindfulness intervention to music listening might enhance the effect on control of attention, with positive effects on cognition and mood poststroke but the feasibility and acceptability of this intervention needs to be evaluated before attempting a further trial assessing the effectiveness of this intervention. The investigators aim to recruit 100 patients within two weeks poststroke.
Participants will be randomly assigned to receive an 8 week music listening alone, music listening with brief mindfulness or audiobook listening intervention alongside treatment as usual. Neuropsychological assessment of cognition and mood will be performed at baseline, 3 months, and 6 months poststroke In addition, participants will be interviewed about their experience of engaging in the interventions.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Stroke | Other: Music with brief mindfulness intervention Other: Music listening alone Other: Audiobook listening | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 100 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Measuring the Effects of Listening for Leisure on Outcome After Stroke (MELLO) |
Study Start Date : | October 2014 |
Estimated Primary Completion Date : | September 2016 |
Estimated Study Completion Date : | September 2016 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Music listening |
Other: Music listening alone |
Experimental: Music listening with brief mindfulness |
Other: Music with brief mindfulness intervention
Music listening with mindfulness therapy |
Placebo Comparator: Audio book intervention |
Other: Audiobook listening |
- Recruitment rate at 6 month follow up from baseline [ Time Frame: 6 months ]
- Treatment adherence at 6 month follow up from baseline [ Time Frame: 6 months ]
- sample retention at 6 month follow up from baseline [ Time Frame: 6 months ]
- Change in overall cognition score at 6 months from baseline [ Time Frame: 6 months ]
- Change in attention, memory and executive function scores at 6 months from baseline [ Time Frame: 6 months ]
- Change in Hospital Anxiety and Depression Scale (HADS) scores at 6 months from baseline [ Time Frame: 6 months ]
- Changes in Five Facet Mindfulness Questionnaire short form (FFMQ-sf) [ Time Frame: 6 months ]
- Changes in Mayo Portland Adaptability Inventory 4 (MPAI-4) scores [ Time Frame: 6 months ]
- Changes in Brain Injury Rehabilitation Trust Regulation of Emotions Adaptability [ Time Frame: 6 months ]
- Changes in Metacognitions Questionnaire short form (MCQ-30) [ Time Frame: 6 months ]
- Likert ratings of participants' and therapist's experiences of treatment delivery. [ Time Frame: 6 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Diagnosis of Ischaemic stroke (confirmed clinically and/or radiologically and subclassified according to the Oxford Clinical Stroke Classification)
- ≤14 days poststroke at time of recruitment (expression of interest to participate either verbally or in writing)
- Native English speaking
Exclusion Criteria:
- Comorbid progressive neurological or neurodegenerative condition
- Major psychiatric disorder (Prestroke history of mood disorder or stable antidepressant medication will not lead to exclusion)
- History of major substance abuse problems
- Unable to give informed consent
- Unable to cooperate with the study protocol (e.g. due to severe aphasia, uncorrected impairment of hearing or vision, or illiteracy)
- Clinically unstable (e.g. due to major intercurrent illness).

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02259062
United Kingdom | |
NHS Greater Glasgow and Clyde | |
Glasgow, United Kingdom |
Principal Investigator: | Jonathan Evans, BSc,Dip.Clin.Psychol. PhD | University of Glasgow |
Responsible Party: | NHS Greater Glasgow and Clyde |
ClinicalTrials.gov Identifier: | NCT02259062 |
Other Study ID Numbers: |
GN13CP462 |
First Posted: | October 8, 2014 Key Record Dates |
Last Update Posted: | July 6, 2016 |
Last Verified: | July 2016 |
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |